Feature | January 21, 2014

Tennessee Center Treats Patients With Proton Therapy

Prostate cancer patients among first to receive advanced, less invasive treatment

Provision Center for Proton Therapy Radiation Therapy
January 21, 2014 — Three prostate cancer patients were among the first to receive treatment at the Provision Center for Proton Therapy in Knoxville, Tenn., the state’s first proton therapy center. 
14 centers in the United States and 46 in the world offer the non-invasive and precise radiotherapy that uses a single beam of high-energy protons to treat various forms of cancer including prostate, pediatric, sarcoma, brain, lung and breast cancers. Proton beams can be within millimeters of accuracy to deliver maximum energy in a controlled range of cancerous tumors. 
Provision Medical Director Marcio Fagundes, M.D., performed the treatments for two Knoxville residents and a North Carolinian. A board-certified radiation oncologist, Dr. Fagundes began treating patients with proton therapy at Harvard Medical School in 1993.
Provision Center for Proton Therapy will have three treatment rooms and capacity to treat up to 900 cancer patients annually. Treatments will typically require daily 30 to 45 minute sessions for two months.
For more information: provisionproton.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init